Four scans, one goal: finding the best way to see if breast cancer treatment is working
NCT ID NCT06879704
Summary
This study aims to find the best combination of imaging scans to predict if a patient's triple-negative breast cancer will completely disappear after receiving chemotherapy and immunotherapy before surgery. Researchers will compare results from four different types of scans (ultrasound, mammography, MRI, and PET-CT) against the actual tissue analysis after surgery. They will also look for blood markers that might predict which patients benefit most from treatment or are at higher risk for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Henri Becquerel
RECRUITINGRouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.